Celyad’s NKR-2 Phase I Safety Trial Delivers Encouraging Results to Be Presented at ASH 2016

7. November 2016 INDIZES USA

Celyad (Paris:CYAD) (Brussels:CYAD) (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...